Lambros Stamatakis MD
Minimally Invasive Surgery, Surgical Oncology
MedStar Washington Hospital Center
Join to view full profile
110 Irving St NwSuite 3b-19Washington, DC 20010
Phone+1 202-877-2252
Dr. Stamatakis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lambros Stamatakis is an urologist in Washington, DC and is affiliated with MedStar Washington Hospital Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 12 years. He specializes in minimally invasive surgery and surgical oncology and is experienced in urologic oncology and minimally invasive urologic surgery.
Education & Training
National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2012 - 2014
Baylor College of MedicineFellowship, Minimally Invasive Urologic Surgery, 2011 - 2012- Baylor College of MedicineResidency, Urology, 2006 - 2011
- Baylor College of MedicineInternship, Transitional Year, 2005 - 2006
University of Maryland School of MedicineClass of 2005
Certifications & Licensure
DC State Medical License 2014 - 2027
MD State Medical License 2012 - 2027
VA State Medical License 2014 - 2016
TX State Medical License 2011 - 2015
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MEDSEEK Empower, SymphonyCare, LLC, 2016-2017
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2016-2017
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2016-2017
Publications & Presentations
PubMed
- 3 citationsBacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer.Matthew Ho, Alon Lazarovich, Ragheed Saoud, Aaron Dahmen, Samuel Tremblay
Urologic Oncology. 2025-11-01 - Financial considerations among adult men undergoing vasectomy: cost analysis and modeling of outpatient costs associated with vasectomy.Samuel Moffet, Tina Lulla, Lambros Stamatakis, Nathan M Shaw
Translational Andrology and Urology. 2025-05-30 - 32 citationsPhase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).Daniel M Geynisman, Philip H Abbosh, Eric Ross, Matthew R Zibelman, Pooja Ghatalia
Journal of Clinical Oncology. 2025-03-20
Authored Content
- To Oophorectomy or Not to Oophorectomy: Practice Patterns Among Urologists Treating Bladder CancerDecember 2017
Press Mentions
Some Patients with Bladder Cancer 'Can't Wait' for Treatment During the COVID-19 PandemicMay 21st, 2020
Trump: Melania Can’t Fly for One Month After Big OperationJune 9th, 2018
Melania Had ‘Big Operation,’ Can’t Fly for a Month, Trump RevealsJune 8th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: